home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 27, 2022
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 455 active entries

Abcepta Inc.

10320 Camino Santa Fe, Suite G
San Diego, 92121
United States of America, California
Toll free: 1-888-735-7227

Phone: 858-622-0099
Fax: 858-622-0609

Description:

Abcepta is a leading manufacturer of primary antibodies with more than a decade of experience. We meet the ever changing demands of research and drug discovery through a thoughtful target selection process and strengthened validation-standards. Moreover, we strive to continuously improve the customer experience through comprehensive technical support, a world class website, and an easy ordering process.

Company highlights:

  • Most antibodies are produced in-house to ensure specificity, affinity, and reproducibility.
  • Over 1,000 new antibodies are released per year with an emphasis on autophagy, stem cells, and neurodegeneration.
  • Striving for proteome-wide antibody coverage.
  • Featuring our “Crown” line of premium antibodies and offering evaluation size vials for more than 10,000 products.

In addition, Abcepta offers the highest quality services including custom antibody development, custom peptide synthesis and custom protein expression. Synthesis of difficult peptides, including long peptides, is a core competency of Abcepta. High quality, rapid turnaround and personal support for all Abcepta services are guaranteed.

Browse our website or contact us directly in order to discover what Abcepta can do for you. We are here to be your partner for scientific research and discovery.

 



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Pharmaceutical
- Research
Supplier
- Research
Contract
- Services

Last update of this entry: November 10, 2022

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2022 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.